Your browser doesn't support javascript.
loading
Quality improvement mechanisms to improve lymph node staging for lung cancer: Trends from a statewide database.
Kalata, Stanley; Reddy, Rishindra M; Norton, Edward C; Clark, Melissa J; He, Chang; Leyden, Thomas; Adams, Kumari N; Popoff, Andrew M; Lall, Shelly C; Lagisetty, Kiran H.
Afiliación
  • Kalata S; Department of Surgery, University of Michigan, Ann Arbor, Mich. Electronic address: stkalata@med.umich.edu.
  • Reddy RM; Department of Surgery, University of Michigan, Ann Arbor, Mich.
  • Norton EC; Departments of Health Management and Policy and Economics, University of Michigan, Ann Arbor, Mich.
  • Clark MJ; Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative, Ann Arbor, Mich.
  • He C; Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative, Ann Arbor, Mich.
  • Leyden T; Blue Cross Blue Shield of Michigan, Detroit, Mich.
  • Adams KN; Department of Thoracic Surgery, St. Joseph Mercy Hospital, Ann Arbor, Mich.
  • Popoff AM; Department of Thoracic Surgery, Henry Ford Hospital, Detroit, Mich.
  • Lall SC; Department of Thoracic Surgery, Munson Medical Center, Traverse City, Mich.
  • Lagisetty KH; Department of Surgery, University of Michigan, Ann Arbor, Mich.
J Thorac Cardiovasc Surg ; 167(4): 1469-1478.e3, 2024 Apr.
Article en En | MEDLINE | ID: mdl-37625618
ABSTRACT

OBJECTIVE:

Our statewide thoracic quality collaborative has implemented multiple quality improvement initiatives to improve lung cancer nodal staging. We subsequently implemented a value-based reimbursement initiative to further incentivize quality improvement. We compare the impact of these programs to steer future quality improvement initiatives.

METHODS:

Since 2016, our collaborative focused on improving lymph node staging for lung cancer by leveraging unblinded, hospital-level metrics and collaborative feedback. In 2021, a value-based reimbursement initiative was implemented with statewide yearly benchmark rates for (1) preoperative mediastinal staging for ≥T2N0 lung cancer, and (2) sampling ≥5 lymph node stations. Participating surgeons would receive additional reimbursement if either benchmark was met. We reviewed patients from January 2015 to March 2023 at the 21 participating hospitals to determine the differential effects on quality improvement.

RESULTS:

We analyzed 6228 patients. In 2015, 212 (39%) patients had ≥5 nodal stations sampled, and 99 (51%) patients had appropriate preoperative mediastinal staging. During 2016 to 2020, this increased to 2253 (62%) patients and 739 (56%) patients, respectively. After 2020, 1602 (77%) patients had ≥5 nodal stations sampled, and 403 (73%) patients had appropriate preoperative mediastinal staging. Interrupted time-series analysis demonstrated significant increases in adequate nodal sampling and mediastinal staging before value-based reimbursement. Afterward, preoperative mediastinal staging rates briefly dropped but significantly increased while nodal sampling did not change.

CONCLUSIONS:

Collaborative quality improvement made significant progress before value-based reimbursement, which reinforces the effectiveness of leveraging unblinded data to a collaborative group of thoracic surgeons. Value-based reimbursement may still play a role within a quality collaborative to maintain infrastructure and incentivize participation.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: J Thorac Cardiovasc Surg Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: J Thorac Cardiovasc Surg Año: 2024 Tipo del documento: Article